|
|
Article: HOECHST MARION ROUSSEL: Improvements for seasonal allergic rhinitis sufferers taking Allegra -- studies.
- Article from:
- M2 Presswire
- Article date:
- March 4, 1999
CopyrightCOPYRIGHT 1999 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-4 March 1999-HOECHST MARION ROUSSEL: Studies demonstrated significant improvements in the daily living of seasonal allergic rhinitis sufferers taking Allegra (Fexofenadine Hydrochloride) (C)1994-99 M2 COMMUNICATIONS LTD
RDATE:020399
ORLANDO, Fl. -- New data presented this week at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) demonstrated that Allegra (fexofenadine hydrochloride) improved the daily living and symptoms associated with seasonal allergic rhinitis (SAR) in patients. The two studies were sponsored by Hoechst Marion Roussel, the pharmaceutical company of Hoechst AG.
Two studies ...